MA
TXG icon

MCF Advisors’s 10x Genomics TXG Stock Holding History

MCF Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Hold
6,431
– – 0.01% 397
2026
Q1 		$137K Hold
6,431
– – 0.01% 454
2025
Q4 		$105K Hold
6,431
– – 0.01% 396
2025
Q3 		$75.2K Hold
6,431
– – ﹤0.01% 363
2025
Q2 		$74.5K Hold
6,431
– – ﹤0.01% 352
2025
Q1 		$56.1K Hold
6,431
– – ﹤0.01% 381
2024
Q4 		$92.3K Buy
+6,431
New +$101K 0.01% 320

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MCF Advisors's TXG Position: Q2 2026 in Review

MCF Advisors held its 10x Genomics (TXG) position steady in Q2 2026 at 6,431 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #397.

MCF Advisors first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • MCF Advisors held 6,431 shares of 10x Genomics worth $247K as of Q2 2026.
  • MCF Advisors left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up 0.01% of MCF Advisors's portfolio in Q2 2026, its #397 holding.
  • MCF Advisors first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.